Metabolic phenotyping of healthy and diseased human RPE cells.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
01 Mar 2024
01 Mar 2024
Historique:
pubmed:
11
3
2024
medline:
11
3
2024
entrez:
11
3
2024
Statut:
epublish
Résumé
Metabolic defects in retinal pigment epithelium (RPE) are underlying many retinal degenerative diseases. This study aims to identify the nutrient requirements of healthy and diseased human RPE cells. We profiled the utilization of 183 nutrients in human RPE cells: 1) differentiated and dedifferentiated fetal RPE (fRPE), 2) induced pluripotent stem cell derived-RPE (iPSC RPE), 3) Sorsby fundus dystrophy (SFD) patient-derived iPSC RPE and its CRISPR-corrected isogenic SFD (cSFD) iPSC RPE, and 5) ARPE-19 cell lines cultured under different conditions. Differentiated fRPE cells and healthy iPSC RPE cells can utilize 51 and 48 nutrients respectively, including sugars, intermediates from glycolysis and tricarboxylic acid (TCA) cycle, fatty acids, ketone bodies, amino acids, and dipeptides. However, when fRPE cells lose epithelial phenotype through dedifferentiated, they can only utilize 17 nutrients, primarily sugar and glutamine-related amino acids. SFD RPE cells can utilize 37 nutrients; however, Compared to cSFD RPE and healthy iPSC RPE, they are unable to utilize lactate, some TCA cycle intermediates, and short-chain fatty acids. Nonetheless, they show increased utilization of branch-chain amino acids (BCAAs) and BCAA-containing dipeptides. The dedifferentiated ARPE-19 cells in traditional culture media cannot utilize lactate and ketone bodies. In contrast, nicotinamide supplementation promotes differentiation into epithelial phenotype, restoring the ability to use these nutrients. Epithelial phenotype confers metabolic flexibility to the RPE for utilizing various nutrients. SFD RPE cells have reduced metabolic flexibility, relying on the oxidation of BCAAs. Our findings highlight the importance of nutrient availability and utilization in RPE differentiation and diseases.
Identifiants
pubmed: 38464098
doi: 10.1101/2024.02.28.582405
pmc: PMC10925320
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NEI NIH HHS
ID : R01 EY034364
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM144230
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY032462
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103434
Pays : United States
Organisme : NICHD NIH HHS
ID : R24 HD000836
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY031324
Pays : United States
Déclaration de conflit d'intérêts
Conflicts of interest The authors declare no conflicts of interest.
Références
Cell Rep. 2022 Feb 1;38(5):110320
pubmed: 35108535
Stem Cell Reports. 2020 Apr 14;14(4):631-647
pubmed: 32243845
J Clin Invest. 2011 Jan;121(1):369-83
pubmed: 21135502
Genome Med. 2015 Jun 19;7(1):58
pubmed: 26150894
Exp Eye Res. 2014 Sep;126:77-84
pubmed: 24485945
J Biol Chem. 2014 Jul 25;289(30):20570-82
pubmed: 24898254
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7085-99
pubmed: 26540654
Mol Metab. 2016 Apr 22;5(7):538-551
pubmed: 27408778
iScience. 2020 Oct 14;23(11):101672
pubmed: 33196018
J Biol Chem. 2017 May 12;292(19):8038-8047
pubmed: 28302729
Orphanet J Rare Dis. 2020 Mar 6;15(1):68
pubmed: 32143654
J Biol Chem. 2022 Sep;298(9):102286
pubmed: 35868562
FASEB J. 2022 Aug;36(8):e22428
pubmed: 35766190
Trends Mol Med. 2020 Jan;26(1):105-118
pubmed: 31771932
J Biol Chem. 2019 Jun 28;294(26):10278-10289
pubmed: 31110046
Elife. 2017 Sep 13;6:
pubmed: 28901286
Amino Acids. 2021 Dec;53(12):1789-1806
pubmed: 33871679
Sci Rep. 2019 Oct 25;9(1):15355
pubmed: 31653972
Cell Rep. 2020 May 5;31(5):107606
pubmed: 32375026
Exp Eye Res. 2019 Feb;179:18-24
pubmed: 30336127
J Neurosci Res. 2019 Jan;97(1):88-97
pubmed: 30129971
EMBO J. 2020 Apr 15;39(8):e103334
pubmed: 32134147
Nat Med. 2016 Apr;22(4):421-6
pubmed: 26950361
Exp Eye Res. 2022 Feb;215:108899
pubmed: 34929159
Amino Acids. 2018 Jan;50(1):29-38
pubmed: 28929384
Int J Mol Sci. 2020 Jun 16;21(12):
pubmed: 32560057
J Biol Chem. 2017 Aug 4;292(31):12895-12905
pubmed: 28615447
Commun Biol. 2019 May 20;2:186
pubmed: 31123710
Cell Metab. 2019 Feb 5;29(2):417-429.e4
pubmed: 30449684
Prog Retin Eye Res. 2016 May;52:47-63
pubmed: 26773759
Annu Rev Vis Sci. 2021 Sep 15;7:665-692
pubmed: 34102066
Front Cell Dev Biol. 2020 Jun 25;8:501
pubmed: 32671066
Front Cell Dev Biol. 2019 Jul 19;7:135
pubmed: 31380370
Cell Metab. 2018 Jun 05;27(6):1281-1293.e7
pubmed: 29779826
J Proteome Res. 2023 Aug 4;22(8):2703-2713
pubmed: 37493966
Prog Retin Eye Res. 2015 Sep;48:1-39
pubmed: 26113213
Genome Med. 2012 Feb 24;4(2):16
pubmed: 22364233
Prog Retin Eye Res. 2020 Feb 24;:100846
pubmed: 32105772
J Proteome Res. 2021 Jan 1;20(1):909-922
pubmed: 32975122
Nat Genet. 1994 Dec;8(4):352-6
pubmed: 7894485
Trends Neurosci. 2023 Dec;46(12):1067-1082
pubmed: 37848361
Invest Ophthalmol Vis Sci. 2018 Mar 20;59(4):AMD41-AMD47
pubmed: 30025108
Exp Eye Res. 2022 Sep;222:109170
pubmed: 35835183
Invest Ophthalmol Vis Sci. 1990 Dec;31(12):2520-8
pubmed: 2176183